Evidence map›Paper›PMID 40797044›Full record

ArticleNature cardiovascular research2025

Preventing the phosphorylation of RyR2 at canonical sites reduces Ca

Jingjing Zheng, Daniela Ponce-Balbuena, Erick B Ríos Pérez, Li Xiao, Holly C Dooge, Héctor H Valdivia, Francisco J Alvarado

Abstract read
In one paragraph

Article in Nature cardiovascular research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Loss of phospholamban phosphorylation blunts CaJournal of molecular and cellular cardiology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. β-Adrenergic Receptors: Not Always Outside-In.Physiology (Bethesda, Md.) · 2026
    Review
  6. Article
  7. L-Type CaCirculation research · 2026
    Article
  8. Article
  9. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Jingjing ZhengDepartment of Medicine, Division of Cardiovascular Medicine, and Cardiovascular Research Center, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
Daniela Ponce-BalbuenaDepartment of Medicine, Division of Cardiovascular Medicine, and Cardiovascular Research Center, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
Erick B Ríos PérezDepartment of Medicine, Division of Cardiovascular Medicine, and Cardiovascular Research Center, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
Li XiaoDepartment of Medicine, Division of Cardiovascular Medicine, and Cardiovascular Research Center, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
Holly C DoogeDepartment of Medicine, Division of Cardiovascular Medicine, and Cardiovascular Research Center, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
Héctor H ValdiviaDepartment of Medicine, Division of Cardiovascular Medicine, and Cardiovascular Research Center, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
Francisco J AlvaradoDepartment of Medicine, Division of Cardiovascular Medicine, and Cardiovascular Research Center, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA. falvarad@medicine.wisc.edu.ORCID http://orcid.org/0000-0003-0552-9029

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Christian Capitini · 1985 to 2026
$142.6M
Ryanodine Receptors, Calcium-dependent Arrhythmias & HCMR01HL055438 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI VALDIVIA, HECTOR H · 1996 to 2023
$8.0M
Rational Design from Cryo-EM Structures of High-Affinity Ryanodine Receptor Ligands Based on Natural PeptidesR01HL170144 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI Hector H Valdivia · 2023 to 2026
$2.6M
Partial and Controlled Depletion of SR Calcium by RyR Agonists Prevents Calcium-dependent ArrhythmiasR01HL167195 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI Francisco J Alvarado, Hector H Valdivia · 2023 to 2026
$2.4M
Mechanisms of calcium-induced arrhythmias in arrhythmogenic right ventricular cardiomyopathyR01HL161070 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI Francisco J Alvarado · 2022 to 2026
$1.9M
Automated Tissue MicroarrayerS10OD023526 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI MATKOWSKYJ, KRISTINA A. · 2018 to 2018
$184k
NCI NIH HHS P30 CA014520NHLBI NIH HHS R01 HL055438NHLBI NIH HHS R01 HL161070NHLBI NIH HHS R01 HL167195NHLBI NIH HHS R01 HL170144NIH HHS S10 OD023526U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) HL055438U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) HL161070U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) HL167195U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) HL170144
6 · The paper itself

Abstract

Phosphorylation of specific sites in ryanodine receptor 2 (RyR2), a major cardiac Ca

Indexed as

Arrhythmias, CardiacCalciumCalcium SignalingMyocytes, CardiacRyanodine Receptor Calcium Release ChannelAction PotentialsAnimalsDisease Models, AnimalHeart RateIsoproterenolMicePhosphorylationSarcoplasmic ReticulumCalciumIsoproterenolryanodine receptor 2. mouseRyanodine Receptor Calcium Release Channel

Identifiers

PMID40797044
PMCPMC12343298

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.